From: MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy
Cancers | Targeted gene products†| References |
---|---|---|
Cancers with down-regulation of miR-330-3p | ||
 | Acting as oncogenes or tumor promoters | |
CRC | TYMS, HK2 | |
GC | MSI1, PRRX1 | |
LSCC | SLC7A11, TRA2B | |
OSCC | GLS | Qian et al. (2021) |
BRCA | MYC | He et al. (2020) |
PCa | BMI1, E2F1 | |
 | Acting both as oncogenes and tumor suppressors, or unclassified) | |
CRC | MYO6, PFN1 | |
NSCLC | GRIA3 | Wei et al. (2019b) |
OVCA | RIPK4 | Cai et al. (2021) |
Cancers with up-regulation of miR-330-3p | ||
 | Acting as tumor suppressors |  |
ESCC | PDCD4 | Meng et al. (2015) |
NSCLC | EGR2, PTEN, RASSF1A | |
BRCA | PDCD4 | Ji et al. (2021) |
HCC | BTG1, ING4 |